Increased expression of IGF ligands and receptors has been observed in tumors of the breast, lung, pancreas, colon, prostate, ovary, and thyroid and is usually associated with a poor prognosis [1,6,14,15]. This evidence concerns the gene IGF1 and neoplasm.